Condition: Cataract · Surgery · Compliance, Patient · Sponsor: University of California, San Francisco
The current postoperative cataract surgery eye drop regimen used at Zuckerberg San Francisco General Hospital (ZSFG) is a significant burden for its patient population, contributing to high rates of non-adherence and the development of postoperative complications. The investigators propose to replace this complex regimen with a single administration of intraocular antibiotic and subconjunctival steroid at the time of surgery. This pilot study will obtain the preliminary data required to eventually fully evaluate this innovation in postoperative care in a safety-net population with respect to postoperative outcomes, patient compliance, and patient and caregiver satisfaction.
This description comes directly from the study's public registry record.
Sriranjani Padmanabhan, MD · 415-514-0241 · sriranjani.padmanabhan@ucsf.edu
Nicole Xin, BA · 628-206-3123 · nicole.xin@ucsf.edu
Always discuss trial participation with your own doctor first.
| Zuckerberg San Francisco General Hospital and Trauma Center (ZSFG) | San Francisco, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05157113